Otc - Active Ingredient
titanium dioxide
Isleaf Cushion Concealer 21
FDA Label NDC 70818-001
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by C3 Co., Ltd. for the product Isleaf Cushion Concealer 21 (NDC 70818-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
wter butylene glycol, beeswas, etc.
Otc - Purpose
brighten around eyes or face
Otc - Keep Out Of Reach Of Children
keep out of reach of the children
Indications & Usage
Click end to release product into brush, then apply to areas you want to perfect and brighten around eyes or face. Repeat until desired coverage is achieved, then pat into skin with fingertips to blend flawlessly.
Warnings
1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other skin irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight
2. Do not use on open wounds, eczema, and other skin irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight
4. Use as avoiding eye areas.
Dosage & Administration
for external use only
Package Label.Principal Display Panel
Label (Label)
* Please review the disclaimer below.
